PIRAMAL PHARMA
Back to Income Statement
|
PIRAMAL PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹9,151 Cr | ₹8,171 Cr | ₹7,082 Cr | ₹6,559 Cr | ₹6,315 Cr |
What is the latest Revenue of PIRAMAL PHARMA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹9,151 Cr |
| Mar2024 | ₹8,171 Cr |
| Mar2023 | ₹7,082 Cr |
| Mar2022 | ₹6,559 Cr |
| Mar2021 | ₹6,315 Cr |
How is Revenue of PIRAMAL PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹9,151 Cr | 11.99 | |
| Mar2024 | ₹8,171 Cr | 15.39 | |
| Mar2023 | ₹7,082 Cr | 7.97 | |
| Mar2022 | ₹6,559 Cr | 3.87 | |
| Mar2021 | ₹6,315 Cr | - | |
Compare Revenue of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹20,330.1 Cr | -4.1% | 0.9% | -25.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -4.1% |
0.9% |
-25.3% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses